BDBM300523 4-hydroxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 93

SMILES O=C(Nc2nnc(c1ccccc1)s2)c5ccc(O)c(NC(=O)C4(N3CCOCC3)CC4)c5

InChI Key InChIKey=WSKTTZMMHNBICS-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 300523   

TargetProtein Wnt-3a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM300523(4-hydroxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbo...)
Affinity DataIC50: 240nMAssay Description:In preparation of the assay, the two cell lines were plated 24 hours before at 10000 cells per well of a 384 micro titre plate (MTP) in 30 μL gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2019
Entry Details
US Patent

TargetProtein Wnt-3a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM300523(4-hydroxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbo...)
Affinity DataIC50: 5.00E+4nMAssay Description:In preparation of the assay, the two cell lines were plated 24 hours before at 10000 cells per well of a 384 micro titre plate (MTP) in 30 μL gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2019
Entry Details
US Patent